The National Institutes of Health (NIH) plays a vital role in advancing medical innovation, ensuring national security, and maintaining public health preparedness. However, funding for NIH is at risk in the FY 2026 appropriations process.
NIH-funded research has led to groundbreaking advancements in blood safety, biotherapies, and innovative treatments such as chimeric antigen receptor T-cell (CAR-T) therapy and Tumor-Infiltrating Lymphocytes (TIL) technologies. These developments are vital for treating hematologic malignancies, solid tumor cancers, and complications related to transfusions in both civilian and military populations.
TAKE ACTION NOW: Send a message to your members of Congress asking them to support robust NIH funding. Every dollar of federal research funding generates an estimated $2.46 in economic activity across the U.S.
Your advocacy is crucial in ensuring continued medical progress and national preparedness. Encourage your colleagues to take action, too!